Cambridge Financial Group (Arizona)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$588K Sell
4,574
-139
-3% -$16.3K 0.19% 92
2026
Q1
$567K Sell
4,713
-1,009
-18% -$116K 0.19% 88
2025
Q4
$575K Buy
5,722
+1,770
+45% +$166K 0.2% 85
2025
Q3
$332K Buy
3,952
+140
+4% +$11.5K 0.11% 134
2025
Q2
$302K Sell
3,812
-640
-14% -$50.9K 0.11% 116
2025
Q1
$399K Sell
4,452
-757
-15% -$70.7K 0.17% 95
2024
Q4
$518K Buy
5,209
+96
+2% +$9.9K 0.22% 72
2024
Q3
$581K Buy
5,113
+253
+5% +$30.1K 0.24% 72
2024
Q2
$602K Buy
4,860
+2
+0% +$258 0.27% 68
2024
Q1
$641K Sell
4,858
-380
-7% -$46.8K 0.3% 64
2023
Q4
$571K Buy
+5,238
New +$544K 0.3% 63

Other funds holding MRK

Cambridge Financial Group (Arizona)'s MRK Position: Q2 2026 in Review

Cambridge Financial Group (Arizona) reduced its Merck (MRK) stake by 2.9% in Q2 2026, selling an estimated $16.3K and leaving 4,574 shares worth $588K. The position accounts for 0.19% of the portfolio, ranked #92.

Cambridge Financial Group (Arizona) first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $641K in Q1 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cambridge Financial Group (Arizona) held 4,574 shares of Merck worth $588K as of Q2 2026.
  • Cambridge Financial Group (Arizona) sold 139 Merck shares in Q2 2026, an estimated $16.3K.
  • Merck made up 0.19% of Cambridge Financial Group (Arizona)'s portfolio in Q2 2026, its #92 holding.
  • Cambridge Financial Group (Arizona) first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Cambridge Financial Group (Arizona)'s Merck position peaked at $641K in Q1 2024.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cambridge Financial Group (Arizona)'s 13F filing for Q2 2026, filed 14 Jul 2026.